INZY
Price
$3.53
Change
-$0.02 (-0.56%)
Updated
Nov 14, 03:23 PM (EDT)
126 days until earnings call
MREO
Price
$3.90
Change
-$0.15 (-3.70%)
Updated
Nov 14, 03:30 PM (EDT)
132 days until earnings call
Ad is loading...

INZY vs MREO

Header iconINZY vs MREO Comparison
Open Charts INZY vs MREOBanner chart's image
Inozyme Pharma
Price$3.53
Change-$0.02 (-0.56%)
Volume$538
CapitalizationN/A
Mereo BioPharma Group
Price$3.90
Change-$0.15 (-3.70%)
Volume$5.45K
CapitalizationN/A
INZY vs MREO Comparison Chart
Loading...
INZY
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
MREO
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
INZY vs. MREO commentary
Nov 14, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is INZY is a Hold and MREO is a StrongSell.

COMPARISON
Comparison
Nov 14, 2024
Stock price -- (INZY: $3.55 vs. MREO: $4.05)
Brand notoriety: INZY and MREO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: INZY: 116% vs. MREO: 103%
Market capitalization -- INZY: $228.05M vs. MREO: $623.1M
INZY [@Biotechnology] is valued at $228.05M. MREO’s [@Biotechnology] market capitalization is $623.1M. The market cap for tickers in the [@Biotechnology] industry ranges from $473.6B to $0. The average market capitalization across the [@Biotechnology] industry is $2.76B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

INZY’s FA Score shows that 0 FA rating(s) are green whileMREO’s FA Score has 1 green FA rating(s).

  • INZY’s FA Score: 0 green, 5 red.
  • MREO’s FA Score: 1 green, 4 red.
According to our system of comparison, MREO is a better buy in the long-term than INZY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

INZY’s TA Score shows that 4 TA indicator(s) are bullish while MREO’s TA Score has 3 bullish TA indicator(s).

  • INZY’s TA Score: 4 bullish, 7 bearish.
  • MREO’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, MREO is a better buy in the short-term than INZY.

Price Growth

INZY (@Biotechnology) experienced а -16.08% price change this week, while MREO (@Biotechnology) price change was -1.22% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.82%. For the same industry, the average monthly price growth was +4.53%, and the average quarterly price growth was +7.12%.

Reported Earning Dates

INZY is expected to report earnings on Mar 20, 2025.

MREO is expected to report earnings on Mar 26, 2025.

Industries' Descriptions

@Biotechnology (-0.82% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MREO($623M) has a higher market cap than INZY($228M). MREO YTD gains are higher at: 75.325 vs. INZY (-16.667). MREO has higher annual earnings (EBITDA): -34.59M vs. INZY (-82.82M). INZY has more cash in the bank: 145M vs. MREO (87.4M). MREO has less debt than INZY: MREO (6.16M) vs INZY (46.7M). MREO has higher revenues than INZY: MREO (1M) vs INZY (0).
INZYMREOINZY / MREO
Capitalization228M623M37%
EBITDA-82.82M-34.59M239%
Gain YTD-16.66775.325-22%
P/E RatioN/AN/A-
Revenue01M-
Total Cash145M87.4M166%
Total Debt46.7M6.16M758%
TECHNICAL ANALYSIS
Technical Analysis
INZYMREO
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
82%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
88%
MACD
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 11 days ago
86%
Bullish Trend 4 days ago
84%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
86%
N/A
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
INZY
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
MREO
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JHQDX18.76N/A
N/A
JPMorgan Hedged Equity 2 I
DNLYX64.82-0.11
-0.17%
BNY Mellon Active MidCap Y
MRLSX20.80-0.05
-0.24%
AMG Renaissance Large Cap Growth I
MCRTX45.98-0.24
-0.52%
Morgan Stanley Insight R6
NIOIX13.66-0.15
-1.09%
Neuberger Berman Intl Small Cap I

INZY and

Correlation & Price change

A.I.dvisor indicates that over the last year, INZY has been loosely correlated with BEAM. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if INZY jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INZY
1D Price
Change %
INZY100%
-5.59%
BEAM - INZY
57%
Loosely correlated
-1.57%
FATE - INZY
53%
Loosely correlated
-8.82%
DNLI - INZY
49%
Loosely correlated
-0.84%
NTLA - INZY
49%
Loosely correlated
-3.24%
AVIR - INZY
48%
Loosely correlated
+0.60%
More

MREO and

Correlation & Price change

A.I.dvisor indicates that over the last year, MREO has been loosely correlated with MDGL. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if MREO jumps, then MDGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MREO
1D Price
Change %
MREO100%
-1.22%
MDGL - MREO
37%
Loosely correlated
-7.05%
INZY - MREO
32%
Poorly correlated
-5.59%
TERN - MREO
32%
Poorly correlated
-5.30%
ARRY - MREO
30%
Poorly correlated
+1.97%
XERS - MREO
29%
Poorly correlated
N/A
More